Go Back

Combining data and cancer care expertise to inform the future of cancer care.

Carevive Systems, Inc. founded in 2013, is an oncology-focused health technology company centered on understanding and improving the experience of patients with cancer. Our platform enables clinicians to monitor and manage their patients remotely, which improves clinical outcomes and patient quality of life. Use of Carevive in the clinic unlocks critical data on the real-world experience of patients with cancer, to continuously improve patient care today and advance cancer drug development. <br/><br/> <a href="https://www.carevive.com/contact-us/" target="_blank" style="color:#4FAFC9;">Learn more about Carevive here</a><br/>

Carevive

CV/COS Webinar: Clip 13

January 1, 2023

One of the questions we recently received touched on the utility of our platform’s data in understanding patient behavior and experiences. We are thrilled to confirm that several of our sites have conducted research on this very topic, examining factors such as time to complete questionnaires, the impact of questionnaire reviews on treatment decisions, and more. This data has been a valuable source for engaging health services research. Currently, we are actively discussing ways to optimize the data we gather passively to support inquiries on PRO implementation and patient engagement, as it holds great potential for quality improvement and enhanced patient care.

Recent Episodes

CensisAI²
View episode

Inside the SPD Revolution: Robby Miller on Embracing CensisAI²

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

resistance
View episode

Inside Oncology Drug Development: Overcoming Resistance with Science

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

organoids
View episode

Growing the Future of Cancer Research: Inside the Promise of Organoids

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert